Search research articles
Contact Us
Filters
Showing results (131-140 of 466) with videos related to
Page
of 47
Sort By:
Transactions of the Association of American Physicians
|
January 1, 1981
High molecular weight kininogen protects human plasma kallikrein and factor XIa against inactivation by plasma protease inhibitors
M Schapira, C F Scott, R W Colman
The Journal of Laboratory and Clinical Medicine
|
November 1, 1992
The contribution of factor V to the coagulant property of pleural fluid
E G Wyshock, S Idell, R W Colman
The Journal of Clinical Investigation
|
February 1, 1982
Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma
M Schapira, C F Scott, R W Colman
The Journal of Clinical Investigation
|
June 1, 1974
Human platelet collagenase
C M Chesney, E Harper, R W Colman
Immunological Communications
|
January 1, 1973
Simple assay for prekallikrein activators
A Bagdasarian, R C Talamo, R W Colman
Thrombosis Research
|
June 1, 2000
Inactivation of platelet PDE2 by an affinity label: 8-[(4-bromo-2, 3-dioxobutyl)thio]cAMP
F Mseeh, R F Colman, R W Colman
The Journal of Clinical Investigation
|
August 1, 1983
Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variants
H C Chiu, E Whitaker, R W Colman
The Journal of Thoracic and Cardiovascular Surgery
|
June 11, 1991
Invited letter concerning: aprotinin
L H Edmunds, S Niewiarowski, R W Colman
Biochimica Et Biophysica Acta
|
February 25, 1982
Coagulation factor V exists uncomplexed in bovine plasma
T R Ittyerah, R Rawala, R W Colman
British Journal of Haematology
|
February 1, 1974
A new haemorrhagic disorder with defective fibrin stabilization and cryofibrinogenaemia
R D Rosenberg, R W Colman, L Lorand
Page
of 47
Search research articles
Search
Showing results (131-140 of 466) with videos related to
Sort By:
Page
of 47
Transactions of the Association of American Physicians
|
January 1, 1981
High molecular weight kininogen protects human plasma kallikrein and factor XIa against inactivation by plasma protease inhibitors
M Schapira, C F Scott, R W Colman
The Journal of Laboratory and Clinical Medicine
|
November 1, 1992
The contribution of factor V to the coagulant property of pleural fluid
E G Wyshock, S Idell, R W Colman
The Journal of Clinical Investigation
|
February 1, 1982
Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma
M Schapira, C F Scott, R W Colman
The Journal of Clinical Investigation
|
June 1, 1974
Human platelet collagenase
C M Chesney, E Harper, R W Colman
Immunological Communications
|
January 1, 1973
Simple assay for prekallikrein activators
A Bagdasarian, R C Talamo, R W Colman
Thrombosis Research
|
June 1, 2000
Inactivation of platelet PDE2 by an affinity label: 8-[(4-bromo-2, 3-dioxobutyl)thio]cAMP
F Mseeh, R F Colman, R W Colman
The Journal of Clinical Investigation
|
August 1, 1983
Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variants
H C Chiu, E Whitaker, R W Colman
The Journal of Thoracic and Cardiovascular Surgery
|
June 11, 1991
Invited letter concerning: aprotinin
L H Edmunds, S Niewiarowski, R W Colman
Biochimica Et Biophysica Acta
|
February 25, 1982
Coagulation factor V exists uncomplexed in bovine plasma
T R Ittyerah, R Rawala, R W Colman
British Journal of Haematology
|
February 1, 1974
A new haemorrhagic disorder with defective fibrin stabilization and cryofibrinogenaemia
R D Rosenberg, R W Colman, L Lorand
Page
of 47